| Withdrawn | Time to Excretion of Contrast, a Maastricht Prospective Observational Study NCT04603261 | Maastricht University Medical Center | — |
| Withdrawn | Maastricht Investigation of Renal Function in Absence of- and Post- Contrast in Patients With eGFR LEss Than 3 NCT04598516 | Maastricht University Medical Center | — |
| Withdrawn | Efficacy of Point-Of-Care Creatinine Assays in Patients With eGFR <30 Receiving Intravascular Contrast NCT04597892 | Maastricht University Medical Center | — |
| Not Yet Recruiting | A Study of the Effect of a Nurse Navigator Program on High Risk Patients NCT05592847 | Mayo Clinic | N/A |
| Not Yet Recruiting | Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD NCT07524101 | Yonsei University | N/A |
| Recruiting | A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Rena NCT07426380 | Eli Lilly and Company | Phase 1 |
| Not Yet Recruiting | A Study of the Pharmacokinetics and Safety of Anaprazole Sodium in Special Populations NCT07345689 | Xuanzhu Biopharmaceutical Co., Ltd. | Phase 4 |
| Active Not Recruiting | A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participant NCT07165015 | Eli Lilly and Company | Phase 1 |
| Recruiting | A Study of LY3537982 in Participants With Kidney Problems Compared With Participants With Normal Kidney Functi NCT07137689 | Eli Lilly and Company | Phase 1 |
| Recruiting | Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave NCT06890208 | Universitätsklinikum Hamburg-Eppendorf | — |
| Recruiting | A Pharmacokinetics and Safety Study of Azvudine Tablets in Subjects With Mild-To-Moderate GFR Decline in Renal NCT07001436 | Henan Genuine Biotech Co., Ltd. | Phase 1 |
| Not Yet Recruiting | To Evaluate the Efficacy and Safety of Tenofovir Alafenamide Conversion in Liver Transplant Patients NCT06589518 | Jongman Kim | Phase 2 |
| Recruiting | Amino Acid Loss During Continuous Renal Replacement Therapy NCT06659835 | Medical University of Vienna | — |
| Completed | Registry of Pre-mixed Solutions in Critically Ill Patients on the Continuous Renal Replacement Therapy NCT06983509 | Vantive Health LLC | — |
| Recruiting | Study of the Quality of Life in School Aged-children With Posterior Urethral Valves NCT06439862 | Hospices Civils de Lyon | — |
| Completed | Chronical Illness-related Limitations of the Ability to Cope with Rising Temperatures: an Observational Study, NCT06407154 | Universitätsklinikum Hamburg-Eppendorf | — |
| Recruiting | Prospective Observational Association Between SLCO1B1 Gene Polymorphism and the Anti-factor Xa Activity of Edo NCT06431789 | Yi Han | — |
| Recruiting | SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study NCT06001827 | VenoStent | N/A |
| Completed | Phase 1 Renal Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride NCT06747520 | Ahon Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | H-Guard Pilot Safety Evaluation in Haemodialysis Patients NCT06070337 | Invizius Limited | N/A |
| Completed | Renal Assist Device (RAD) for Patients With Renal Insufficiency Undergoing Cardiac Surgery NCT05990660 | 3ive Labs | N/A |
| Terminated | Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study NCT05961163 | Universitätsklinikum Hamburg-Eppendorf | — |
| Recruiting | DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Mul NCT06354231 | Fudan University | Phase 2 |
| Completed | A Study of LY3502970 in Participants With Normal and Impaired Renal Function NCT05936138 | Eli Lilly and Company | Phase 1 |
| Completed | A Study to Determine Pharmacokinetic Changes of Ceftriaxone in Patients With Liver Cirrhosis NCT05960006 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | — |
| Recruiting | Food Frequency Questionnaire to Assess Sodium Intake NCT05533645 | University Hospital, Lille | N/A |
| Completed | A Study of LY3819469 in Participants With Impaired and Normal Renal Function NCT05841277 | Eli Lilly and Company | Phase 1 |
| Unknown | Reduction of Metabolic Acidosis in Patients With Chronic Kidney Disease in Stage 4 and 5 NCT05784389 | Nordsjaellands Hospital | N/A |
| Completed | A Study of LY3473329 in Participants With Impaired and Normal Renal Function NCT05778864 | Eli Lilly and Company | Phase 1 |
| Unknown | Safety of Short Hydration Method for Cisplatin Administration Compared With Conventional Hydration NCT05884905 | Mahidol University | N/A |
| Completed | Reduction of Metabolic Acidosis in Patients With Chronic Kidney Disease in Stage 4 and 5 NCT05970094 | University of Copenhagen | N/A |
| Completed | Association Between COVID-19 and UTIs Caused by ESBL Organism in Infants NCT05630326 | Hamad Medical Corporation | — |
| Completed | A Study to Test How BI 1015550 is Taken up in the Blood of People With and Without Kidney Problems NCT05718648 | Boehringer Ingelheim | Phase 1 |
| Completed | A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Kidney Problems NCT05718843 | Boehringer Ingelheim | Phase 1 |
| Completed | Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal NCT05624723 | Incyte Corporation | Phase 1 |
| Unknown | External Validation of the VExUS Score for the Prediction of Acute Renal Failure in Cardiac Surgery NCT05640518 | University Hospital, Grenoble | — |
| Recruiting | Renal Function After Stentgraft Treatment Of Abdominal Aortic Aneurysm NCT04754659 | Vastra Gotaland Region | N/A |
| Completed | A Study to Evaluate the Pharmacokinetics and Safety of INCB054707 in Participants With Normal Hepatic Function NCT05624710 | Incyte Corporation | Phase 1 |
| Completed | A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function NCT05611957 | Eli Lilly and Company | Phase 1 |
| Recruiting | Tolerability and Safety of CARDIOMEMS™ Intracardiac Continuous Cardiac Hemodynamic Monitoring Device in Patien NCT05428631 | Centre Hospitalier Universitaire de Nīmes | N/A |
| Recruiting | Extended-Release Tacrolimus Following Liver Transplantation NCT05242315 | University of Alberta | Phase 4 |
| Completed | A Study of Epetraborole Tablets in Subjects With Degrees of Renal Function NCT05283746 | AN2 Therapeutics, Inc | Phase 1 |
| Unknown | Spironolactone in CKD Enabled by Chlorthalidone: PILOT NCT05222191 | Indiana Institute for Medical Research | Phase 2 |
| Unknown | PErirenal Adipose Tissue and RenaL Hemodynamics in Patients With Heart Failure With Preserved Ejection Fractio NCT05219188 | University Medical Center Groningen | — |
| Completed | Sonographic Examination of Renal Function in Individuals With Long-term Spinal Cord Injury NCT04241666 | Swiss Paraplegic Research, Nottwil | — |
| Unknown | The Effect of TaiChi on Ischemic Burden of Patients With Coronary Heart Disease Complicated With Renal Insuffi NCT05178602 | Beijing Anzhen Hospital | N/A |
| Completed | Preoperative Renal Insufficiency Predicts Postoperative Adverse Outcomes NCT05455528 | Taipei Medical University Hospital | — |
| Recruiting | Comparison of HYDROLINK™ and HeprAN™ mEmbranes in a Per Dialytic Heparin Weaning Strategy in Chronic Hemodialy NCT05117450 | CHU de Reims | N/A |
| Unknown | HOLT-ED: Holter-monitoring in End-stage Renal Disease NCT04876963 | Rigshospitalet, Denmark | — |
| Completed | Study to Evaluate Safety and Tolerability of Iberdomide (CC-220) in Participants With Kidney Impairment Compar NCT04933747 | Celgene | Phase 1 |
| Completed | Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants NCT04922645 | USRC Kidney Research | Phase 4 |
| Active Not Recruiting | SelfWrap-Assisted Arteriovenous Fistulas NCT05418816 | VenoStent | N/A |
| Unknown | Clinical Study of POSS-PCU Vascular Grafts for Vascular Access NCT02301312 | University College, London | N/A |
| Completed | Renal Involvement in Hospitalized Children With COVID-19 NCT04788394 | Hamad Medical Corporation | — |
| Unknown | Changes in Weight, Body Composition and Metabolic Parameters After Discontinuing Dolutegravir or Tenofovir Dis NCT04903847 | Thomas Benfield | Phase 4 |
| Completed | Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Kidney Function and Healthy Participants NCT06190678 | Eli Lilly and Company | Phase 1 |
| Completed | Telmisartan Versus Enalapril in Heart Failure With Reduced Ejection Fraction Patients With Moderately Impaired NCT04736329 | Cairo University | N/A |
| Unknown | Transcatheter Implantation of Aortic Bioprosthesis Without the Use of Iodinated Contrast in Patients With Chro NCT04581694 | University of Sao Paulo General Hospital | N/A |
| Terminated | A Study to Evaluate the Effect of Renal Impairment on JNJ-56136379 in Adult Participants NCT04474210 | Janssen Research & Development, LLC | Phase 1 |
| Completed | Pharmacokinetic Study of Aztreonam-Avibactam in Severe Renal Impairment NCT04486625 | Pfizer | Phase 1 |
| Completed | Study of 2 Modalities of Dialysis and Nutrition on the Nutritional Status of Malnourished Chronic Renal Diseas NCT04445558 | GCS Ramsay Santé pour l'Enseignement et la Recherche | N/A |
| Completed | A Phase 1 Study to Evaluate the Pharmacokinetics of Setmelanotide in Subjects With Varying Degrees of Renal Im NCT04348175 | Rhythm Pharmaceuticals, Inc. | Phase 1 |
| Unknown | Evaluation of Macro and Microcirculatory Arterial Condition of the Upper Limb in Insufficiently Renal Patients NCT04451018 | University Hospital, Grenoble | — |
| Completed | Effectiveness of Chronic Kidney Disease Nurse-led Self-management Program (CKD-NLSM) NCT03974646 | Universiti Putra Malaysia | N/A |
| Unknown | The Safety and Efficacy of Micro-energy Ultrasound in the Treatment of Renal Insufficiency After Renal Transpl NCT04119427 | Second Affiliated Hospital, School of Medicine, Zhejiang University | N/A |
| Completed | Collection of Data of Ceftobiprole Treated Patients: Comparison of Patients With and Without Certain Diseases NCT04170309 | Advanz Pharma | — |
| Completed | Hemofilter Life Span, ECLS And/or CRRT NCT04193865 | Medical University of South Carolina | — |
| Withdrawn | The Water Intake Trail and Primary Aldosteronism Postoperation(WIT-PAP) NCT04150666 | Qifu Li | N/A |
| Unknown | TDF Dose Adjustment VS. Switching to TAF in TDF-experienced CHB Patients With Renal Impairment NCT04391608 | Mahidol University | Phase 4 |
| Completed | Study Assessing PK and Safety of MGTA-145 in Subjects With Normal Estimated GFR and Varying Degrees of Renal I NCT04154670 | Ensoma | Phase 1 |
| Unknown | Rivaroxaban in Elderly NVAF Patients With or Without Renal Impairment NCT04096547 | Samsung Medical Center | — |
| Completed | Study of the Way the Body Takes up, Distributes, and Gets Rid of ACT-541468 in Subjects With Abnormal Kidney F NCT04024332 | Idorsia Pharmaceuticals Ltd. | Phase 1 |
| Not Yet Recruiting | Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions NCT03899298 | R3 Stem Cell | Phase 1 |
| Unknown | Pirfenidone Capsule in Patients With Chronic Kidney Disease G2 and G3a Study on Safety and Pharmacokinetics NCT04126538 | Beijing Continent Pharmaceutical Co, Ltd. | Phase 1 |
| Completed | A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems NCT03814005 | Takeda | Phase 1 |
| Completed | Concordance Between the Foot-to-Apex Systolic Interval and the Auscultatory Method for Measurement of Brachial NCT04043871 | Centre Hospitalier Universitaire de Nīmes | — |
| Completed | Elafibranor Pharmacokinetic Parameters in Renal Impaired Patients NCT03844555 | Genfit | Phase 1 |
| Completed | XIENCE 28 USA Study NCT03815175 | Abbott Medical Devices | N/A |
| Completed | Ultra Low Iodine Loaded Spectral CT Angiography (CTA) NCT05488899 | University Hospital, Akershus | N/A |
| Active Not Recruiting | Effects of SGLT2 Inhibitors on Erythropoiesis in Heart Failure NCT07478575 | University Medical Centre Ljubljana | — |
| Completed | A Study of Effect of Selpercatinib (LY3527723) in Participants With Normal and Impaired Renal Function NCT05469100 | Eli Lilly and Company | Phase 1 |
| Completed | A One Visit Follow Up of Adults With Fabry Disease Who Started Long-term Enzyme Replacement Therapy As Childre NCT04002531 | Baylor Research Institute | N/A |
| Unknown | Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women NCT03767803 | Progenity, Inc. | — |
| Unknown | Renal Function Post Cardioversion for Atrial Fibrillation NCT02742207 | Hadassah Medical Organization | — |
| Completed | A Study to Look at the Effect MEDI0382 Has on Blood Sugar in People With Type 2 Diabetes and Kidney Problems a NCT03550378 | MedImmune LLC | Phase 2 |
| Completed | The Effect of Three Endourological Procedures for the Management of Renal Calculi Regarding Acute Kidney Injur NCT03112499 | Institute for the Study of Urological Diseases, Greece | N/A |
| Withdrawn | A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy Participants NCT03545087 | Eli Lilly and Company | Phase 1 |
| Unknown | High Resolution Imaging of Retinal Vessels as a Biomarker of Cardiovascular Disease in Patients With Renal Ins NCT04116814 | Ramsay Générale de Santé | — |
| Completed | A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function NCT03482024 | Eli Lilly and Company | Phase 1 |
| Completed | Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in Participants With R NCT03311841 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Remote Ischemic Preconditioning for Renal Protection in TAVI NCT03347032 | Henry Ford Health System | N/A |
| Completed | XIENCE 28 Global Study NCT03355742 | Abbott Medical Devices | N/A |
| Completed | Heart and Renal Failure in Hip Fracture Surgery NCT03532919 | Sahlgrenska University Hospital | — |
| Completed | Pharmacokinetics of Antiepileptics in Patients on CRRT NCT03632915 | University of Maryland, Baltimore | — |
| Unknown | Safety and Efficacy of High Protein Diet Versus GFR Based Protein Diet in Heart Failure Patients With Renal In NCT03213821 | Rajaie Cardiovascular Medical and Research Center | N/A |
| Completed | A Study to Evaluate Pharmacokinetics, Safety and Tolerability of MEDI0382 in Renal Impairment Subjects NCT03235375 | MedImmune LLC | Phase 1 |
| Completed | A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 1467335 i NCT03302091 | Boehringer Ingelheim | Phase 1 |
| Completed | Pharmacokinetics, Dialysability and Safety of P03277 in Healthy Volunteers and in Patients With Impaired Renal NCT03657784 | Guerbet | Phase 1 |
| Completed | BIA Versus Physician Adjustment in Acute Kidney Injury Patients Requiring Renal Replacement Therapy NCT03916861 | Bangkok Metropolitan Administration Medical College and Vajira Hospital | N/A |
| Completed | A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of JNJ-64041575 in Adult Participan NCT03189498 | Janssen Pharmaceutica N.V., Belgium | Phase 1 |
| Completed | Pharmacokinetics and Safety of Fevipiprant in Patients With Renal Impairment Compared to Matched Healthy Subje NCT03087942 | Novartis Pharmaceuticals | Phase 1 |
| Completed | Comparative Study of the Efficacy of Oral Versus Intravenous Hydration as a Preventive Measure of Contrast-ind NCT02872155 | David Garcia Cinca | Phase 3 |
| Completed | The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FAST PV and mGFR Technology™ NCT03095391 | FAST BioMedical | — |
| Completed | Preserve-Transplant Study NCT03102996 | University of Zurich | Phase 4 |
| Completed | The Pharmacokinetics of Gefapixant (MK-7264) in Participants With Renal Insufficiency (MK-7264-026) NCT03108924 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | A Study to Assess the Pharmacokinetics of CC-122 in Subjects With Mild, Moderate, and Severe Renal Impairment NCT03097016 | Celgene | Phase 1 |
| Completed | Effect of Evogliptin on Albuminuria in Patients With Type 2 Diabetes and Renal Insufficiency NCT03667300 | Samsung Medical Center | Phase 2 |
| Completed | Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mo NCT02668250 | Centre Hospitalier Universitaire de Saint Etienne | N/A |
| Completed | A Study to Evaluate the Effect of Severe Renal Impairment on the Single-dose Pharmacokinetics of Odalasvir NCT02961660 | Janssen Research & Development, LLC | Phase 1 |
| Completed | Empagliflozin in Renal Transplant Recipients NCT03157414 | Oslo University Hospital | Phase 4 |
| Withdrawn | Remote Ischemic Preconditioning in ACS Patients NCT03329612 | Henry Ford Health System | N/A |
| Terminated | Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants NCT02664155 | Centre Hospitalier Universitaire de Saint Etienne | Phase 3 |
| Completed | Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201 NCT02894385 | Bayer | Phase 1 |
| Completed | A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of AL-335 NCT02894905 | Janssen Research & Development, LLC | Phase 1 |
| Completed | Sodium Intake in Chronic Kidney Disease (STICK) NCT02458248 | University College Hospital Galway | Phase 2 |
| Withdrawn | A Study to Evaluate the Pharmacokinetics Of Sativex® in Subjects With Severe Renal Impairment or End Stage Ren NCT02325024 | GW Pharmaceuticals Ltd | Phase 1 |
| Completed | Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers NCT02780414 | Progenity, Inc. | — |
| Completed | Safety Study of Cenderitide in Chronic Stable Heart Failure With Moderate Renal Impairment NCT02603614 | Capricor Inc. | Phase 1 / Phase 2 |
| Unknown | DEB-after-Cutting Balloon-PTA in Dialysis Fistula Stenosis NCT02578784 | Cantonal Hospital of St. Gallen | N/A |
| Unknown | Effects of Cholecalciferol on Osteoprotegerin Levels in Patients on Peritoneal Dialysis NCT02598635 | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Phase 4 |
| Completed | Factors Related to Geographical Variation in the Incidence of End-stage Renal Failure: An Analysis in 5 French NCT02849964 | Centre Hospitalier Universitaire de Besancon | — |
| Completed | Atorvastatin in the Recipient's Kidney Graft From a Living Donor NCT02522117 | Instituto Mexicano del Seguro Social | Phase 3 |
| Completed | Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects and Subjects With Renal Impairment NCT02653014 | KBP Biosciences | Phase 1 |
| Completed | Evaluation of ESPAIR, an Educational Therapy's Program of Patients With Renal Insufficiency Before Kidney Tran NCT02468440 | University Hospital, Toulouse | N/A |
| Completed | Renal PRotection Against Contrast mEdium-induced nephroPathy in High Risk Patients undErgoing Coronary Angiogr NCT02463604 | University Hospital, Angers | N/A |
| Completed | Optimal Administration of Allopurinol in Dialysis Patients NCT02477488 | Maisonneuve-Rosemont Hospital | Phase 4 |
| Completed | Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D NCT02492620 | Denver Nephrologists, P.C. | Phase 3 |
| Completed | Renal Allograft Tolerance Through Mixed Chimerism (Belatacept) NCT02314403 | Massachusetts General Hospital | Phase 1 |
| Completed | Novel Biomarkers for Risk Prediction of Contrast-Induced Acute Kidney Injury Post Coronary Angiography NCT02263820 | Sapere Bio | — |
| Completed | Clinical Pharmacology of FYU-981 (Subjects With Renal Insufficiency) NCT02347046 | Fuji Yakuhin Co., Ltd. | Phase 1 |
| Completed | Timing of Coronary Angiography, Cardiac Surgery, and Adverse Renal and Cardiac Events (MARCE) NCT02332070 | Baylor Research Institute | — |
| Unknown | Pilot Study for the Evaluation of the Safety and Performance of the RenaSense System in Hospitalized Acute Dec NCT02324400 | Nephera Ltd. | Phase 1 / Phase 2 |
| Terminated | Preventing Contrast-induced Nephropathy: Evaluating Hydration Strategies and L-carnitine Administration NCT01786824 | Centre Hospitalier Universitaire de Nīmes | Phase 3 |
| Completed | Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects NCT02320045 | Intarcia Therapeutics | Phase 1 |
| Unknown | Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen NCT03672110 | Technische Universität Dresden | Phase 3 |
| Completed | Clinical Trial in Patients With Hypertension and Left Ventricular Dysfunction NCT02148991 | Elpen Pharmaceutical Co. Inc. | — |
| Completed | SP2086 Pharmacokinetic Study in Renal Insufficiency Patients NCT02815774 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Completed | Afatinib in Subjects With Kidney Dysfunction NCT02096718 | Boehringer Ingelheim | Phase 1 |
| Completed | PK and PD Study of IDN-6556 in Subjects With Severe Renal Impairment and Matched Healthy Volunteers NCT02039817 | Conatus Pharmaceuticals Inc. | Phase 1 |
| Completed | Assessing the Behavior of Met DR in Subjects With Kidney Dysfunction NCT01658514 | Elcelyx Therapeutics, Inc. | Phase 2 |
| Withdrawn | Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal Dysfunction NCT01407900 | John A. Schirger | Phase 1 |
| Completed | Pharmacokinetics of Sugammadex (MK-8616) in Participants With Moderate and Severe Renal Insufficiency (MK-8616 NCT02011490 | Merck Sharp & Dohme LLC | Phase 1 |
| Terminated | Pharmacokinetics, Safety and Tolerability of the Combination of BI 207127 and Faldaprevir in Renal Impaired Pa NCT01957657 | Boehringer Ingelheim | Phase 1 |
| Withdrawn | The Pharmacokinetics of MK-7145 Following Single Dose Administration in Participants With Moderate Renal Insuf NCT01832103 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | PF-04634817 Renal Impairment Study NCT01791855 | Pfizer | Phase 1 |
| Terminated | Low-dose VS High-dose IV Cyclophosphamide for Proliferative LN in Children NCT01861561 | Mahidol University | Phase 4 |
| Completed | Efficacy and Safety of a Double Icodextrin Dose in Elderly Incident CAPD Patients on Incremental PD. NCT01944852 | Pr Eric Goffin | Phase 4 |
| Completed | Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis NCT01742611 | Astellas Pharma Inc | Phase 3 |
| Completed | Pharmacokinetic Evaluation of Tirofiban Using a Single High-Dose Bolus In Subjects With Varying Degrees of Ren NCT01766154 | Medicure | Phase 1 |
| Unknown | Efficacy and Safety of Alprostadil Prevent Contrast Induced Nephropathy NCT01722513 | Shanghai 10th People's Hospital | Phase 4 |
| Completed | A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis NCT01742585 | Astellas Pharma Inc | Phase 3 |
| Withdrawn | Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients NCT01809730 | NYU Langone Health | — |
| Completed | Biomarkers Correlation With Volemia NCT01858675 | ThermoFisher Scientific Brahms Biomarkers France | N/A |
| Completed | Pharmacokinetic Assessment of Single-Dose Odanacatib (MK-0822) in Subjects With Severe Renal Insufficiency (MK NCT01512667 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Study in Patients With Untreated Multiple Myeloma and Renal Insufficiency NCT01337752 | Novartis Pharmaceuticals | Phase 2 |
| Completed | Anti-inflammatory Effect of Atorvastatin on Graft Donor Kidney NCT02355704 | Instituto Mexicano del Seguro Social | Phase 3 |
| Recruiting | Product Surveillance Registry NCT01524276 | Medtronic | — |
| Completed | Pharmacokinetics of Certoparin in Subjects With Renal Insufficiency and Healthy Subjects NCT01660295 | Novartis Pharmaceuticals | Phase 1 / Phase 2 |
| Completed | Pharmacokinetics of Peginterferon Alfa-2b in Participants With Moderate and Severe Renal Impairment (P05655) NCT01432535 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Safety Use of ATeGe in Liver Transplant Recipients With Pre-transplant Renal Dysfunction NCT01453218 | Hospital Vall d'Hebron | Phase 3 |
| Completed | A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to NCT01407874 | BioCryst Pharmaceuticals | Phase 2 |
| Completed | PK Study of ACHN-490 Injection in Renally Impaired Subjects NCT01462136 | Achaogen, Inc. | Phase 1 |
| Completed | Comparison of Markers of Kidney Function NCT01403766 | University of California, Los Angeles | — |
| Completed | Dexpramipexole Renal PK Study NCT01424176 | Knopp Biosciences | Phase 1 |
| Completed | Pharmacodynamic Comparison of Truncal Blocks in Patients With or Without Metabolic Disease (Kidney Failure, Di NCT01323075 | Centre Hospitalier Universitaire de Nīmes | — |
| Completed | Observational Study on the Incidence of NSF in Renal Impaired Patients Following Dotarem Administration NCT01467271 | Guerbet | — |
| Completed | Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Ki NCT01560572 | University Medical Center Groningen | Phase 4 |
| Terminated | De Novo Everolimus-based Therapy for Renal Transplantation Using Rituximab Induction NCT01312064 | National Taiwan University Hospital | Phase 4 |
| Completed | A Study of Erythromycin and Rivaroxaban in Study Participants With Normal and Reduced Kidney Function NCT01309438 | Janssen Research & Development, LLC | Phase 1 |
| Completed | Pharmacokinetics (PK) of Dalfampridine-ER 7.5 mg BID in Healthy Volunteers and Subjects With Mild or Moderate NCT01316055 | Acorda Therapeutics | Phase 1 |
| Completed | Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal Insufficiency NCT01172431 | West China Hospital | Phase 4 |
| Completed | Taurolock for Preventing Bacterial Peritonitis During Renal Insufficiency NCT01101087 | Centre Hospitalier Universitaire de Nīmes | N/A |
| Completed | Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment NCT01164501 | Boehringer Ingelheim | Phase 3 |
| Completed | An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Hav NCT01064414 | Janssen Research & Development, LLC | Phase 3 |
| Completed | Effect of Remote Ischaemic Preconditioning on Renal Function in Patients Undergoing Living Donor Kidney Transp NCT01289548 | Huazhong University of Science and Technology | N/A |
| Completed | A Single-Dose, Pharmacokinetic/Pharmacodynamic (PK/PD), & Safety Study of BIIB017 in Participants With Renal I NCT01119781 | Biogen | Phase 1 |
| Unknown | Study of an Intervention to Improve Problem List Accuracy and Use NCT01105923 | Brigham and Women's Hospital | N/A |
| Completed | "Pharmacokinetic Study of Fondaparinux in Inpatients With Renal Dysfunction" NCT01121770 | Duke University | Phase 1 |
| Completed | A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis NCT01057407 | Astellas Pharma Inc | Phase 3 |
| Completed | Safety and Efficacy of Low Dose Hypertonic Saline Solution and High Dose Furosemide for Congestive Heart Failu NCT01028170 | Aspirus Heart and Vascular Institute-Research and Education | Phase 3 |
| Completed | Clinical Study to Investigate the Safety and Pharmacokinetics of SK3530 Tablet in Renal Impaired Male Patients NCT01232010 | Asan Medical Center | Phase 1 |
| Completed | A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis NCT01017276 | Astellas Pharma Inc | Phase 3 |
| Completed | Clinical Study to Investigate the Safety and Pharmacokinetics of Udenafil Tablet in Renal Impaired Male Patien NCT01231997 | Asan Medical Center | Phase 1 |
| Terminated | Tetraspan 6 Percent (%) Combined With Sterofundin ISO Versus Albumin 5 Percent (%) Combined With Sodium Chlori NCT00936247 | B. Braun Melsungen AG | Phase 4 |
| Unknown | Colour Coded Duplex Ultrasound of Native Arterio-venous Fistula for Haemodialysis With Venous Pressure Measure NCT01001000 | University of Zurich | — |
| Completed | A Pharmacokinetic Study of Abiraterone Acetate in Male Participants With Impaired Renal Function Compared to I NCT01715259 | Cougar Biotechnology, Inc. | Phase 1 |
| Unknown | A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Family Members NCT00994188 | Tokushukai Medical Group | N/A |
| Unknown | A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Third Parties NCT00980317 | Tokushukai Medical Group | N/A |
| Completed | Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis NCT00892749 | Astellas Pharma Inc | Phase 3 |
| Completed | Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-en NCT00908310 | GE Healthcare | Phase 4 |
| Completed | Pain Management After Cardiac Surgery - Opioids or NSAID NCT02479165 | Aalborg University Hospital | Phase 4 |
| Completed | Risk Factors of the Revisit of the Adult Heart Failure Patients in Emergency Department Siriraj Hospital NCT01373775 | Mahidol University | — |
| Terminated | Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal Insuffic NCT00927602 | Università degli Studi dell'Insubria | Phase 4 |
| Terminated | Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency NCT00745316 | Biogen | Phase 2 |
| Withdrawn | Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK I NCT00811863 | Guerbet | — |
| Completed | Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency NCT00911625 | Loyola University | Phase 4 |
| Unknown | Impact of Early Renal Involvement on the Development of Severe In-hospital Renal Failure NCT00806039 | Saint Louis VA Medical Center | N/A |
| Completed | Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administra NCT00744939 | Bayer | — |
| Completed | Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myel NCT00721734 | Amgen | Phase 2 |
| Completed | Evaluation of the Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Without NCT00773409 | Bracco Diagnostics, Inc | — |
| Completed | Two-Point Measurement of Glomerular Filtration Rate by Iohexol Plasma Disappearance NCT01545531 | University of Washington | — |
| Completed | Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe NCT00765830 | Novartis | Phase 3 |
| Completed | Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal I NCT00770081 | Novartis | Phase 3 |
| Terminated | A Single Dose Study Investigating the Elimination as Well as the Tolerability of PD 0332334 in Healthy Subject NCT00721422 | Pfizer | Phase 1 |
| Completed | Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Fai NCT00709865 | Biogen | Phase 3 |
| Unknown | Behaviour and Cognitive Evaluation for Dialysis Elderly Patients (BCDE) NCT00847275 | Nantes University Hospital | N/A |
| Completed | Pharmacokinetics (PK) and Metabolism of FTY720 in Patients With Severe Renal Impairment and Healthy Matched Su NCT00731523 | Novartis | Phase 1 |
| Completed | Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Single and Multiple Doses of Linagliptin Tablet NCT02191228 | Boehringer Ingelheim | Phase 1 |
| Completed | A Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Volunt NCT01759576 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 1 |
| Completed | Evaluation of the Risk of NSF Following ProHance Injection in Patients With Chronic Kidney Disease NCT00600834 | Bracco Diagnostics, Inc | — |
| Completed | Evaluation of the Risk of NSF Following MultiHance Injection in Patients With Chronic Kidney Disease NCT00600951 | Bracco Diagnostics, Inc | — |
| Completed | Renal Safety Evaluation After Dotarem®-Enhanced MRI NCT00650845 | Guerbet | Phase 4 |
| Terminated | Concentrated Saline Infusions and Increased Dietary Sodium With Diuretics for Heart Failure With Kidney Dysfun NCT00575484 | Barnes-Jewish Hospital | Phase 2 |
| Unknown | Renal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart Failure NCT00527059 | University of Roma La Sapienza | Phase 4 |
| Completed | Clinical Assessment of a New Catheter Surface Coating With Antimicrobial Properties NCT00621712 | Vantive Health LLC | N/A |
| Completed | A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney NCT00501462 | GlaxoSmithKline | Phase 1 |
| Completed | Examining New Diagnostic Tests for Acute Kidney Injury After Heart Surgery NCT00774137 | Yale University | — |
| Terminated | Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC NCT00338455 | Scios, Inc. | Phase 2 |
| Unknown | Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia NCT00358046 | Ilypsa | Phase 2 |
| Unknown | HaemoDYNAMICs in Primary and Secondary Hypertension NCT01742702 | Tampere University | — |
| Terminated | COOL RCN: Cooling to Prevent Radiocontrast Nephropathy NCT00306306 | Radiant Medical | Phase 2 / Phase 3 |
| Completed | Study to Assess Bemiparin Pharmacokinetics in Renal Insufficiency and in the Elderly NCT00413088 | Rovi Pharmaceuticals Laboratories | Phase 1 |
| Completed | Multiple Intervention and AUdit in Renal Diseases to Optimize Care NCT00566033 | Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy | Phase 4 |
| Completed | Pharmacokinetics of Dalteparin in Patients With Impaired Renal Function NCT00264693 | Luzerner Kantonsspital | — |
| Completed | Influence of Perioperative Kidney Function on Postoperative Outcome NCT01522313 | Charite University, Berlin, Germany | — |
| Completed | Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairm NCT00159614 | NovaCardia, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 2 |
| Terminated | Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography NCT00209417 | GE Healthcare | Phase 4 |
| Completed | Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With and Witho NCT02182024 | Boehringer Ingelheim | Phase 1 |
| Terminated | Trial of Calcineurin Inhibitor-Sparing Immunosuppression Regimen in Pediatric Liver Transplantation NCT00656266 | Baylor College of Medicine | Phase 4 |
| Completed | Dalteparin's Influence on Renally Compromised: Anti-Ten-A Study (DIRECT) NCT00138099 | Hamilton Health Sciences Corporation | — |
| Completed | BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS) NCT00186329 | Stanford University | Phase 4 |
| Completed | A Study of The Effectiveness of N-Acetylcysteine in Kidney Protection Following Cardiopulmonary Bypass NCT00187330 | Sunnybrook Health Sciences Centre | Phase 2 |
| Completed | Effects of Creatine Supplementation on Renal Function NCT00465140 | University of Sao Paulo | N/A |
| Completed | Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants NCT00580047 | University of Nebraska | N/A |
| Completed | Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction NCT00119691 | Brigham and Women's Hospital | Phase 2 |
| Completed | Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis NCT01207297 | Zhejiang University | Phase 1 |
| Completed | A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008) NCT00418366 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Study to Evaluate the Effects of Underlying Renal or Hepatic Dysfunction on the Pharmacokinetics of Nevirapine NCT02184091 | Boehringer Ingelheim | Phase 1 |
| Completed | The Pharmacokinetic, Safety and Tolerability of Tiotropium in Outpatients With Renal Impairment in Comparison NCT02172339 | Boehringer Ingelheim | Phase 1 |
| Enrolling By Invitation | EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV NCT02699736 | Rigshospitalet, Denmark | — |